Toggle Main Menu Toggle Search

Open Access padlockePrints

Crystallographic fragment screening in academic cancer drug discovery

Lookup NU author(s): Dr Mathew Martin, Professor Jane Endicott, Professor Martin NobleORCiD, Dr Natalie TatumORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2023Fragment-based drug discovery (FBDD) has brought several drugs to the clinic, notably to target proteins once considered to be challenging, or even undruggable. Screening in FBDD relies upon observing and/or measuring weak (millimolar-scale) binding events using biophysical techniques or crystallographic fragment screening. This latter structural approach provides no information about binding affinity but can reveal binding mode and atomic detail on protein-fragment interactions to accelerate hit-to-lead development. In recent years, high-throughput platforms have been developed at synchrotron facilities to screen thousands of fragment-soaked crystals. However, using accessible manual techniques it is possible to run informative, smaller-scale screens within an academic lab setting. This chapter describes general protocols for home laboratory-scale fragment screening, from fragment soaking through to structure solution and, where appropriate, signposts to background, protocols or alternatives elsewhere.


Publication metadata

Author(s): Martin MP, Endicott JA, Noble MEM, Tatum NJ

Publication type: Book Chapter

Publication status: Published

Book Title: Methods in Enzymology

Year: 2023

Volume: 690

Pages: 211-234

Print publication date: 17/10/2023

Online publication date: 11/07/2023

Acceptance date: 02/04/2023

Series Title: Methods in Enzymology

Publisher: Academic Press Inc.

Place Published: San Diego

URL: https://doi.org/10.1016/bs.mie.2023.06.021

DOI: 10.1016/bs.mie.2023.06.021


Share